ECSP099722A - PIRIDO COMPOUNDS [2, 3-D] PIRIMIDINA-7-ONA AS PI3K-ALFA INHIBITORS FOR CANCER TREATMENT - Google Patents
PIRIDO COMPOUNDS [2, 3-D] PIRIMIDINA-7-ONA AS PI3K-ALFA INHIBITORS FOR CANCER TREATMENTInfo
- Publication number
- ECSP099722A ECSP099722A EC2009009722A ECSP099722A ECSP099722A EC SP099722 A ECSP099722 A EC SP099722A EC 2009009722 A EC2009009722 A EC 2009009722A EC SP099722 A ECSP099722 A EC SP099722A EC SP099722 A ECSP099722 A EC SP099722A
- Authority
- EC
- Ecuador
- Prior art keywords
- compounds
- pirimidina
- pirido
- ona
- pi3k
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La invención se refiere a compuestos de la fórmula I: Iy sus sales o solvatos farmacéuticamente aceptables, así como a métodos de preparación y uso de los compuestos.The invention relates to compounds of the formula I: I and their pharmaceutically acceptable salts or solvates, as well as methods of preparation and use of the compounds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91116007P | 2007-04-11 | 2007-04-11 | |
PCT/US2008/004807 WO2008127712A1 (en) | 2007-04-11 | 2008-04-11 | Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP099722A true ECSP099722A (en) | 2009-12-28 |
Family
ID=39642739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2009009722A ECSP099722A (en) | 2007-04-11 | 2009-11-09 | PIRIDO COMPOUNDS [2, 3-D] PIRIMIDINA-7-ONA AS PI3K-ALFA INHIBITORS FOR CANCER TREATMENT |
Country Status (26)
Country | Link |
---|---|
US (2) | US20100209340A1 (en) |
EP (1) | EP2142544B8 (en) |
JP (1) | JP2010523681A (en) |
KR (1) | KR20090130104A (en) |
CN (1) | CN101711249A (en) |
AU (1) | AU2008239596B2 (en) |
BR (1) | BRPI0810175A2 (en) |
CA (1) | CA2683820A1 (en) |
CO (1) | CO6241119A2 (en) |
CR (1) | CR11098A (en) |
DO (1) | DOP2009000242A (en) |
EA (1) | EA018964B1 (en) |
EC (1) | ECSP099722A (en) |
ES (1) | ES2425068T3 (en) |
HK (1) | HK1139941A1 (en) |
IL (1) | IL201209A0 (en) |
MA (1) | MA31336B1 (en) |
MX (1) | MX2009010815A (en) |
MY (1) | MY150747A (en) |
NI (1) | NI200900183A (en) |
NZ (1) | NZ579945A (en) |
SV (1) | SV2009003389A (en) |
TN (1) | TN2009000389A1 (en) |
UA (1) | UA101315C2 (en) |
WO (1) | WO2008127712A1 (en) |
ZA (1) | ZA200906648B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006065703A1 (en) * | 2004-12-13 | 2006-06-22 | Sunesis Pharmaceuticals, Inc. | Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
BRPI0617159B8 (en) * | 2005-10-07 | 2021-05-25 | Exelixis Inc | pi3ka inhibitor pyridopyrimidinone compounds, compositions containing them, and preparation process |
JP5270353B2 (en) * | 2005-10-07 | 2013-08-21 | エクセリクシス, インク. | Phosphatidylinositol 3-kinase inhibitor and method of use thereof |
AU2007284562B2 (en) | 2006-08-16 | 2013-05-02 | Exelixis, Inc. | Using PI3K and MEK modulators in treatments of cancer |
WO2008032162A1 (en) | 2006-09-15 | 2008-03-20 | Pfizer Products Inc. | Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors |
UA100979C2 (en) | 2007-04-10 | 2013-02-25 | Экселиксис, Инк. | Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha |
EP2142543B8 (en) * | 2007-04-11 | 2013-07-03 | Exelixis, Inc. | Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
PA8843901A1 (en) * | 2008-09-30 | 2010-05-26 | PI3K PYRIMIDINONE INHIBITORS (ALFA) AND m TOR | |
US20120040950A1 (en) * | 2009-12-22 | 2012-02-16 | Vertex Pharmaceuticals Incorporated | Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
TW201139436A (en) | 2010-02-09 | 2011-11-16 | Exelixis Inc | Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitors |
WO2012037204A1 (en) | 2010-09-14 | 2012-03-22 | Exelixis, Inc. | Inhibitors of pi3k-delta and methods of their use and manufacture |
WO2013056067A1 (en) * | 2011-10-13 | 2013-04-18 | Exelixis, Inc. | Compounds for use in the treatment of basal cell carcinoma |
CN107375289A (en) | 2011-11-01 | 2017-11-24 | 埃克塞利希斯股份有限公司 | For treating the compound as the kinase inhibitor of phosphatidylinositols 3 of lymphoproliferative malignant tumour |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2937284A (en) * | 1958-05-01 | 1960-05-17 | Burroughs Wellcome Co | 2, 4-diamino-5, 6-dialkylpyrido (2, 3-d) pyrimidines and method |
IL117923A (en) * | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
US7019002B2 (en) * | 2001-12-11 | 2006-03-28 | Pharmacia & Upjohn, S.P.A. | Pyridopyrimidinones derivatives as telomerase inhibitors |
US20080255162A1 (en) * | 2004-05-04 | 2008-10-16 | Warner-Lambert Company Llc | Pyrrolyl Substituted Pyrido[2,3-D]Pyrimidin-7-Ones and Derivatives Thereof as Therapeutic Agents |
CA2624965A1 (en) * | 2005-10-07 | 2007-04-19 | Exelixis, Inc. | Pyridopyrimidinone inhibitors of pi3k.alpha. |
BRPI0617159B8 (en) * | 2005-10-07 | 2021-05-25 | Exelixis Inc | pi3ka inhibitor pyridopyrimidinone compounds, compositions containing them, and preparation process |
AU2007284562B2 (en) * | 2006-08-16 | 2013-05-02 | Exelixis, Inc. | Using PI3K and MEK modulators in treatments of cancer |
WO2008032162A1 (en) * | 2006-09-15 | 2008-03-20 | Pfizer Products Inc. | Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors |
-
2008
- 2008-04-11 AU AU2008239596A patent/AU2008239596B2/en not_active Ceased
- 2008-04-11 JP JP2010503085A patent/JP2010523681A/en active Pending
- 2008-04-11 MX MX2009010815A patent/MX2009010815A/en active IP Right Grant
- 2008-04-11 US US12/595,233 patent/US20100209340A1/en not_active Abandoned
- 2008-04-11 EA EA200970936A patent/EA018964B1/en not_active IP Right Cessation
- 2008-04-11 NZ NZ579945A patent/NZ579945A/en not_active IP Right Cessation
- 2008-04-11 CN CN200880018758A patent/CN101711249A/en active Pending
- 2008-04-11 BR BRPI0810175-2A2A patent/BRPI0810175A2/en not_active IP Right Cessation
- 2008-04-11 KR KR1020097023146A patent/KR20090130104A/en not_active Application Discontinuation
- 2008-04-11 CA CA002683820A patent/CA2683820A1/en not_active Abandoned
- 2008-04-11 EP EP08742864.5A patent/EP2142544B8/en active Active
- 2008-04-11 UA UAA200911451A patent/UA101315C2/en unknown
- 2008-04-11 ES ES08742864T patent/ES2425068T3/en active Active
- 2008-04-11 MY MYPI20094194 patent/MY150747A/en unknown
- 2008-04-11 WO PCT/US2008/004807 patent/WO2008127712A1/en active Application Filing
-
2009
- 2009-09-23 ZA ZA200906648A patent/ZA200906648B/en unknown
- 2009-09-24 TN TNP2009000389A patent/TN2009000389A1/en unknown
- 2009-09-29 IL IL201209A patent/IL201209A0/en unknown
- 2009-10-09 DO DO2009000242A patent/DOP2009000242A/en unknown
- 2009-10-09 SV SV2009003389A patent/SV2009003389A/en not_active Application Discontinuation
- 2009-10-09 NI NI200900183A patent/NI200900183A/en unknown
- 2009-10-30 MA MA32314A patent/MA31336B1/en unknown
- 2009-11-09 EC EC2009009722A patent/ECSP099722A/en unknown
- 2009-11-09 CO CO09126919A patent/CO6241119A2/en not_active Application Discontinuation
- 2009-11-09 CR CR11098A patent/CR11098A/en unknown
-
2010
- 2010-07-07 HK HK10106576.7A patent/HK1139941A1/en not_active IP Right Cessation
-
2013
- 2013-01-03 US US13/694,772 patent/US20130343988A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MA31336B1 (en) | 2010-04-01 |
EA200970936A1 (en) | 2010-02-26 |
IL201209A0 (en) | 2010-05-31 |
CA2683820A1 (en) | 2008-10-23 |
US20100209340A1 (en) | 2010-08-19 |
UA101315C2 (en) | 2013-03-25 |
HK1139941A1 (en) | 2010-09-30 |
AU2008239596B2 (en) | 2013-08-15 |
MX2009010815A (en) | 2009-10-29 |
US20130343988A1 (en) | 2013-12-26 |
CO6241119A2 (en) | 2011-01-20 |
JP2010523681A (en) | 2010-07-15 |
DOP2009000242A (en) | 2010-04-30 |
EP2142544B8 (en) | 2013-07-03 |
ES2425068T3 (en) | 2013-10-11 |
AU2008239596A1 (en) | 2008-10-23 |
EP2142544B1 (en) | 2013-05-22 |
TN2009000389A1 (en) | 2010-12-31 |
NZ579945A (en) | 2012-05-25 |
NI200900183A (en) | 2010-10-05 |
CR11098A (en) | 2010-01-27 |
CN101711249A (en) | 2010-05-19 |
EP2142544A1 (en) | 2010-01-13 |
WO2008127712A1 (en) | 2008-10-23 |
EA018964B1 (en) | 2013-12-30 |
KR20090130104A (en) | 2009-12-17 |
SV2009003389A (en) | 2010-04-27 |
MY150747A (en) | 2014-02-28 |
ZA200906648B (en) | 2010-04-28 |
BRPI0810175A2 (en) | 2014-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP099722A (en) | PIRIDO COMPOUNDS [2, 3-D] PIRIMIDINA-7-ONA AS PI3K-ALFA INHIBITORS FOR CANCER TREATMENT | |
UY31254A1 (en) | SUBSTITUTED DERIVATIVES OF N4- (5-METHYL-1H-PIRAZOL-3-IL) - 1,3,5-TRIAZINA-2,4-DIAMINE, THEIR ENANTIOMERS, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS, PREPARATION PROCESSES AND APPLICATIONS | |
CO6620050A2 (en) | Aminopyrimidine derivatives as modulators of lrrk2 | |
CR20140548A (en) | ARIL-SULTAMO DERIVATIVES AS RORC MODULATORS | |
SV2010003598A (en) | TIAZOL DERIVATIVES USED AS PI 3-CINASA INHIBITORS | |
UY29781A1 (en) | DIAZASPIRO SUBSTITUTE COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS OR SALTS, PREPARATION METHODS AND USES | |
ECSP109856A (en) | DERIVATIVES OF OXADIAZOL AND ITS USE AS POTENTIALS OF METABOTROPIC RECEIVERS OF GLUTAMATE - 842 | |
ECSP13012611A (en) | PIRAZOL-AMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF THE LRRK2 | |
CR20120130A (en) | BENZOXEPINE COMPOUNDS INHIBITORS OF THE PI3K AND METHODS OF USE | |
UY30498A1 (en) | NEW CLASS OF BENZIMIDAZOLILO COMPOUNDS, ITS SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
CR20120414A (en) | DERIVATIVES OF ARILMETOXI ISOINDOLINA AND COMPOSITIONS THAT INCLUDE THEM AND METHODS TO USE THE SAME | |
UY31940A (en) | SUBSTITUTED DERIVATIVES OF 4,5- (SUBSTITUTED-PIRIDIN-3-IL) -1-METHYL-1H-INDOL, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, POLYMORPHOS, ROTÁMEROS, PRO-DRUGS, ANANTIOMERS, HYDRATES, SOLVATOS OF THE SAME AND COMPOSITIONS | |
CU20110145A7 (en) | SULFONAMIDE DERIVATIVES | |
UY31918A (en) | FGFR INHIBITING PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCESSES FOR THE PREPARATION AND USE AS A MEDICINAL PRODUCT | |
NI201000004A (en) | TRISUSTITUED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES. | |
UY31127A1 (en) | METABOTROPIC RECEIVER OXYADAZOL LIGANDS FOR GLUTAMATE AND ITS USE AS POTENTIALS - 841 | |
UY30282A1 (en) | CHEMICAL COMPOUNDS | |
CU20110078A7 (en) | CARBAZOL COMPOUNDS | |
UY31885A (en) | DERIVED FROM THE 1, 3, 5-TRIAZINA-2, 4-DIAMINAS-6-SUBSTITUTED-N-SUBSTITUTED AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS AND APPLICATIONS. | |
DOP2014000036A (en) | PIRIDAZINONE COMPOUNDS AND ITS USE AS DAAO INHIBITORS | |
ECSP13012596A (en) | ELABORATION PROCESS FOR PIRIMIDINE DERIVATIVES | |
UY31048A1 (en) | NEW PIRIMIDINE COMPOUNDS AND USES OF THE SAME | |
BR112012029647A2 (en) | new pyrimidine derivatives | |
ECSP099751A (en) | DERIVATIVES OF 9- (PIRAZOL-3-IL) -9H-PURIN-2-AMINA AND 3- (PIRAZOL-3-IL) -3H-IMIDAZO [4,5-B] PIRIDIN-5-AMINA AND ITS USE FOR CANCER TREATMENT | |
DOP2009000200A (en) | DERIVATIVES OF 2-AMINO-5,7-DIHIDRO-6H-PIRROLO [3,4-D] PIMIRIDINE AS HSP-90 INHIBITORS TO TREAT CANCER |